Three Billion, Continued External Growth... Last Year's Sales Doubled Compared to Previous Year
Three Billion, an artificial intelligence rare disease company, announced on the 11th that its sales doubled last year compared to the previous year, leveraging its global growth.
Based on the pre-audit preliminary settlement, Three Billion recorded sales of 5.8 billion KRW last year, an increase of 112% compared to the previous year.
Following a threefold increase in sales in 2023 compared to the previous year, the company continued to grow rapidly last year.
Last year's operating loss was 7.4 billion KRW, slightly down from 8.4 billion KRW the previous year. Employment growth and facility investments continued to support this growth.
Hot Picks Today
"Should Get at Least 45 Million Won Salary" "Can't Give Up on Large Companies"... Young People Say There Are No Places to Apply
- Unemployment Benefits to Drop from 1.98 Million to 1.76 Million Won per Month...Employment Insurance Premium Rate to Rise from 1.8% to 2%
- Packed Crowds with “It’s So Cheap!”... Japan Travel by UK Millennials & Gen Z Surges 25% in a Year
- "Only One Restroom Break per Semester During Class"…Controversy Over Chinese High School Regulations
- When "Cutting Down Reserved Tents" Brings Relief: Local Governments Take Action Against Escalating 'Reserved Tent' Problem
The rare disease genetic testing service showed steady growth in over 70 countries worldwide, driving Three Billion's sales growth. The company's overseas sales ratio exceeds 70%. The company explained that the customer repurchase rate is as high as 80%, indicating strong trust.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
